<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363171">
  <stage>Registered</stage>
  <submitdate>18/10/2012</submitdate>
  <approvaldate>19/10/2012</approvaldate>
  <actrnumber>ACTRN12612001121853</actrnumber>
  <trial_identification>
    <studytitle>Asian Diabetes Quality of Life Study (AD-QOL)</studytitle>
    <scientifictitle>Development, validation of a new quality of life assessment tool in type 2 diabetes and cross-sectional study to assess the quality of life among diabetics in Malaysia</scientifictitle>
    <utrn>U1111-1136-0270</utrn>
    <trialacronym />
    <secondaryid>NIL</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>observational study for 12 months:
At visit one, subject's quality of life will be assessed using the new tool (AD-QOL), their baseline blood results will be charted ( fasting blood sugar and glycated hemoglobin HBA1C levels). Subject will be given the standard medical care from their respective care-givers. The same procedure will be done at 6 months and 12 months interval.</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Quality of life assessment score using the newly developed Asian Diabetes Quality of Life questionnaire</outcome>
      <timepoint>First visit, 6 months and 12 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Glycated haemoglobin level (HBA1C)</outcome>
      <timepoint>First visit, 6 months and 12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Subjects diagnosed with Type 2 diabetes, with or without pharmacological treatment.
Subjects above the age of 18 and below the age of 80.
Subjects whom have completed secondary education (12 years of formal education) so as to be able to understand the contents of the questionnaire
Subjects who are able to give written consent.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Subjects with concurrent Parkinsons disease, Alzheimers disease, dementia, severe visual impairment.

Subjects less than 18 years of age or more than 80 years of age.

Subjects whom have not completed 12 years of formal education.

Subjects with mental illness impairing judgment who will be unable to give valid consent.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>600</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state>Kuala Lumpur</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state>Johor Bahru</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr.Shereen Goh Giap Kah</primarysponsorname>
    <primarysponsoraddress>1, Jalan BU1/14,
Bandar Utama,
47800, Selangor</primarysponsoraddress>
    <primarysponsorcountry>Malaysia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Monash University Malaysia</fundingname>
      <fundingaddress>Jalan Lagoon Selatan,
Bandar Sunway,46150 Selangor</fundingaddress>
      <fundingcountry>Malaysia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Prof. Dr. Rusli Bin Nordin</sponsorname>
      <sponsoraddress>Jalan Lagoon Selatan,
Bandar Sunway,46150 Selangor</sponsoraddress>
      <sponsorcountry>Malaysia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Prof.Dr. Khalid Abdul Kadir</sponsorname>
      <sponsoraddress>Jalan Lagoon Selatan,
Bandar Sunway,46150 Selangor</sponsoraddress>
      <sponsorcountry>Malaysia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Objectives:
1)	
The primary objective is to conduct a survey to assess the suitability of current available quality of life questionnaires for use in our local Malaysian diabetic population.
2)	 To develop and validate a socially and culturally adapted quality of life measurement scale to successfully measure the quality of life among Malaysian diabetic population that can be projected to the Asian population in the future.
3)	To measure the QOL among Malaysian diabetics and to analyze the factors that contributes to determining QOL.
4)	To determine if diabetes control is an important factor for QOL using a perspective study.
5)	To measure QOL in other south-east Asia countries using the newly developed ADQOL and to compare with Malaysian population.

Methodology
The study is divided into 5 main parts as follows:
I.	Survey to assess the understanding of the local population to the current available quality of life assessment tools.
II.	The development and validation of the Asian Diabetes Quality of Life (AD-QOL) questionnaire to accurately measure the quality of life in a multi-cultural, multi-language population.
III.	Cross-sectional study to assess the QOL among diabetics in Malaysia using AD-QOL.
IV.	Prospective study of diabetics in Malaysia 
V.	Cross countries study of QOL among diabetics using ADQOL.</summary>
    <trialwebsite>nil</trialwebsite>
    <publication>nil</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Monash University Human Research Ethics (MUHREC)</ethicname>
      <ethicaddress>Monash University,  
Building 3E, Room 111, Clayton Campus, Wellington Road, Clayton Vic 3800, Australia</ethicaddress>
      <ethicapprovaldate>28/03/2012</ethicapprovaldate>
      <hrec>CF2630 - 2011001537</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Prof. Khalid Abdul Kadir</name>
      <address>20&amp;22, PJS 11/5, Bandar Sunway, 46150 Petaling Jaya, Selangor</address>
      <phone>+60356211623</phone>
      <fax>+60356211625</fax>
      <email>khalid.kadir@monash.edu</email>
      <country>Malaysia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr.Shereen Goh</name>
      <address>20&amp;22, PJS 11/5, Bandar Sunway, 46150 Petaling Jaya, Selangor</address>
      <phone>+60123397825</phone>
      <fax>+60356211625</fax>
      <email>Shereenggk@hotmail.com</email>
      <country>Malaysia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr.Shereen Goh</name>
      <address>20&amp;22, PJS 11/5, Bandar Sunway, 46150 Petaling Jaya, Selangor</address>
      <phone>+60123397825</phone>
      <fax>+60356211625</fax>
      <email>shereenggk@hotmail.com</email>
      <country>Malaysia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>